Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of. At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics. As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality. To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions. As a key member of the CMC Leadership Team, the Executive Director, Supply Chain, will drive the strategic vision, operational execution, and regulatory compliance of our clinical supply operations. This role is responsible for ensuring the seamless and compliant global distribution of investigational medicinal products, supporting clinical programs critical to our pipeline. Reporting to the SVP, Manufacturing & Supply Chain, this leader will collaborate cross-functionally with Clinical Development, Clinical Operations, Regulatory, Quality, CMC, and Commercial teams, providing senior-level guidance on clinical supply strategy. ESSENTIAL JOB FUNCTIONS:
- Responsible for leading and developing drug supply strategy, planning, and overall management of all aspects of drug supply chain activities including global Phase I - III clinical studies as well as commercial drug supply chain activities.
- Responsible for providing strategic leadership and vision for Investigational Medicinal Supply Chain (IMSC) and associated department staff.
- Responsible for providing operational leadership and oversight of commercial drug packaging, labeling, distribution and 3PL activities in collaboration with the commercial sales organization.
- Responsible for management of IMSC activities and demonstrating operational excellence in developing, and executing interdependent workflows with Clinical Operations, Quality Assurance and Global Project Team management to ensure successful Drug Development Activities are achieved across all areas of IMSC deliverables.
- Contribute vital tactical support and leadership in supply chain and logistics management while identifying and pursuing strategic opportunities to improve IMSC capacity, forecasting & planning models, all IP materials including comedications, comparators, and processes, IVRS management, and overall IMSC performance and efficiencies.
- Establish operating policies and procedures and provide comprehensive coordination of complex global supply chain operations, inventories, materials, and procurement while ensuring compliance to worldwide regulations and guidelines.
- Coordinate drug supply delivery timelines with Clinical and CMC; Packaging, Labeling, and Distribution CRO's; and indirectly with GMP manufacturers, QA, and Regulatory Affairs.
- Lead the team in monitoring and tracking global clinical supply inventories at the clinical site level for studies; maintain forecasts and provide inventory and logistics management of IP adjusting drug distribution plans with coordination of packaging, labeling at Contract Packaging and Procurement Vendors.
- Provide IMSC project leadership and management, and act as knowledgeable resource for establishment of effective collaboration with Clinical Operations for seamless delivery of IP to patients worldwide.
- Manage extensive internal and external touchpoints and maintain close communications with all IMSC groups to ensure the adequate supply of clinical supplies throughout the duration of multiple WW clinical trials including oversight of drug order requests, resupply, and processes.
- Support financial planning for global clinical supplies, including budgeting, forecasting, and strategic planning activities for clinical trials; and reconciliation of drug distribution invoices with finance staff to maximize productivity, efficiency, and overall business performance.
- Contribute and review the preparation of clinical protocols, clinical trial pharmacy manuals, packaging methods, batch records, drug labels, shipping documents, destruction certification, and coordinate the origination, proofing and translation of clinical study labels and generation and updating with quality assurance all IMSC related SOP's.
JOB SPECIFICATIONS:
- Technical degree or equivalent (BS / MS), preferably in a scientific or pharmaceutical discipline
- 15+ years of leadership experience in the pharmaceutical or biotech industry, with a proven track record of leading and scaling clinical supply chain organizations.
- Demonstrated ability to set and execute long-term strategic goals for clinical supply chain operations, ensuring alignment with corporate objectives.
- Extensive experience engaging with executive leadership teams, including presenting strategic plans, risk mitigation strategies, and operational performance metrics.
- Proven success managing complex global supply chain operations, including vendor partnerships, contract negotiations, and compliance with international regulatory agencies (FDA, EMA, PMDA, etc.).
- Strong financial acumen, including oversight of clinical supply budgets, cost efficiency initiatives, and long-term investment planning.
- Enterprise-wide leadership experience, with the ability to influence and collaborate across departments, ensuring clinical supply chain integration into R&D and commercial strategies.
- Track record of building and leading high-performing teams, including succession planning, talent development, and organizational effectiveness.
- Proven expertise in managing regulatory inspections, audits, and compliance strategies in collaboration with Quality and Regulatory Affairs.
- Deep technical knowledge of clinical trial supply planning, including forecasting, IVRS/IRT systems, inventory management, and GMP/GCP compliance.
- Exceptional executive communication skills, with experience presenting to senior leadership, external partners, and regulatory agencies.
TRAVEL REQUIREMENTS:
- Travel between US offices and may require other meeting locations internationally
The base range for this role is $260,647 - $307,515 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.
Kura's Values that are used for candidate selection and performance assessments:
- We work as one for patients
- We are goal-focused and deliver with excellence
- We are science-driven courageous innovators
- We strive to bring out the best in each other and ourselves
The Kura Package
- Career advancement/ development opportunities
- Competitive comp package
- Bonus
- 401K + Employer contributions
- Generous stock options
- ESPP Plan
- 20 days of PTO to start
- 18 Holidays (Including Summer & Winter Break)
- Generous Benefits Package with a variety of plans available with a substantial employer match
- Paid Paternity/Maternity Leave
- In-Office Catered lunches
- Home Office Setup
- Lifestyle Spending Stipend
- Commuter Stipend (Boston Office)
- Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!
Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company's diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology's approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts. Kura's pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura's website atwww.kuraoncology.comand follow us onXandLinkedIn. Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
|